Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM Study

By afschroeder • July 6, 2025

Aggarwal R, Schessl J, Bata-Csörgő Z, Dimachkie MM, Griger Z, Moiseev S, Oddis CV, Schiopu E, Vencovský J, Clodi E, Levine T, Charles-Schoeman C; ProDERM investigators. Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM Study. Rheumatol Ther. 2025 Jul 5. doi: 10.1007/s40744-025-00775-5. Epub ahead of print. PMID: 40616720.

Tags: Arthralgia, Arthritis, Constitutional, Dermatomyositis, gastrointestinal, Immunoglobulins, Intravenous, Octagam, Publications, pulmonary, Rheumatology, Skeletal

Androgen receptor inhibitor double therapies in the management of metastatic castration-sensitive prostate cancer: a cost-effectiveness analysis

Padula WV, Cohen BG, Steel P, Appukkuttan S, Kalayeh B, Rettig M. Androgen receptor inhibitor double therapies in the management of metastatic castration-sensitive prostate cancer:[...]

Alpha-1 Antitrypsin PiMZ Heterozygosity in the Setting of Alcohol-Associated Cirrhosis: A Case Report

Ather N, Mwengela D, Blakey J. Alpha-1 Antitrypsin PiMZ Heterozygosity in the Setting of Alcohol-Associated Cirrhosis: A Case Report. Cureus. 2026 Sep 6;18(9):e115864. doi: 10.7759/cureus.115864.[...]

Triple M Overlap Syndrome: A Rare Complication of Immune Checkpoint Inhibitors

Morris B. Triple M Overlap Syndrome: A Rare Complication of Immune Checkpoint Inhibitors. Cureus. 2026 Sep 6;18(9):e115859. doi: 10.7759/cureus.115859. PMID: 42841091; PMCID: PMC13641304.